The Hotspotters Retention and VL Supression Monitoring Project Ivy Clinic, Arnot Ogden Medical Center DRAFT Quality Improvement Team  Clinical Coordinator.

Slides:



Advertisements
Similar presentations
Quality Improvement Team
Advertisements

Missoula City-County Health Department/ Partnership Health Center Missoula, MT Erin Chambers (406) National Quality Center.
HIV Care Continuum, Men Who Have Sex with Men Only (MSMO) and Men Who Have Sex with Men and Women (MSMW), Georgia, 2012.
Funded by HRSA HIV/AIDS Bureau Selecting an Indicator & Collecting Performance Data Barbara M Rosa, RN-C, MS.
HIV Care Continuum for the United States and Puerto Rico National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
Harlem ID Clinic QI Viral Load Suppression Harlem Hospital Center Michael Serlin, MD Medical Director, Harlem Family Center October 9, 2013.
Integrating Evidence-Based Practice Into QI to Improve Patient Outcomes in HIV: Viral Load Suppression Victoria Lieb, ACRN, MPH; Carla Rossi, MD; Jaime.
HIV INTERVENTION FOR PROVIDERS (HIP) Principal Investigators:  Carol Dawson Rose, RN, Ph.D. and Grant Colfax, MD. Co-Investigators:  Cynthia Gomez, Ph.D.,
HAART and Viral Load Comparison Report Tamarra Jones, DrPH, CHES Orange County Health Care Agency HIV Planning and Coordination Manager.
Positive Living Navajo AIDS Network, Inc. Melvin Harrison, Executive Director Marco Arviso, Arizona Medical Case Manager.
Quality Management Chart Review Pamela Casey, MS, RD June 24, 2014.
Texas Medical Monitoring Project (MMP) Meeting Omni Austin Hotel at Southpark Thursday, May 31, 2007 a multi-stage probability sample of HIV infected adults.
Outcome of 2009 Quality Management Site Visits. OAMC – Outpatient/Ambulatory Medical Care, MCM – Medical Case Management, SA – Substance Abuse Readiness,
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
USING URS for QUALITY MANAGEMENT Case Study 1: “How many of the women currently enrolled in the RWCA case management program are actually receiving routine.
Oversight of a Patient-Centered Infrastructure To Continuously Improve Patient Retention and Viral Load Suppression Rates Moderator: Mindy Golatt, RN,
Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.
HIV Care Continuum, District 8- 2 Southwest (Albany), Georgia, 2012.
This is not Jeopardy!. Rectangle of Retention Public Health slide3 Likely Retention “Bennys” Slide 6 Role Play slide 9 Chicken or egg? Slide.
Positive Living Navajo AIDS Network, Inc. Melvin Harrison, Executive Director Marco Arviso, Arizona Medical Case Manager.
HIV Care Continuum, Georgia, United States, 2011 Presented to American Public Health Association, Annual Meeting Presented by Deepali Rane, MBBS, MPH,
HIV Care Continuum New Diagnoses, 2011, Fulton County, Georgia.
HIV Care Continuum, District 10 Northeast (Athens), Georgia, 2012.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
2014 HIV.STD.TB.Viral Hepatitis Symposium. Program Staff Lindsey VanderBusch – Program Manager Sarah.
Comprehensive Field Record. Introduction to the Training ● The slides will first show a picture of the section of the template that will be discussed.
1 Evaluating Effectiveness of Georgia’s PATH Services Charley Bliss PATH Grantee Meeting December 8 & 10, 2010.
Audit of outcomes in HIV BHIVA Audit and Standards Sub-Committee E Ong (chair), J Anderson, D Churchill, M Desai, S Edwards, S Ellis, A Freedman, P Gupta,
PROJECT IN-CARE Chicago’s Positive Charge Project Roman Buenrostro, AIDS Foundation of Chicago Sunday July 22, 2012.
Mean HIV viral load among resident cases and undiagnosed in Oregon Jeff Capizzi, Epidemiologist Sean Schafer, HIV/STD/TB Medical Epidemiologist Lea Bush,
HIVQUAL – ARV Management October 17, 2003 Saneese Stephen, RPA Kings County Hospital Center Center for H.O.P.E.
Sub module 3 Pre-ART and ART registers. Purpose of registers Key individual information for: Facilitating patient management by the identification of.
Los Angles LGBT Center Noah Kaplan MSW Alex Adame MSW.
HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent
Clinica Bienestar Philadelphia FIGHT and Prevention Point Philadelphia Laura Bamford, Miguel Munoz-Laboy, Andres Freire, Ana Rose, and Jose Benitez.
Choosing Quality Measures for HIV Care and Services The Quality Academy Tutorial 8.
Multi-Sectoral Provincial Strategic Plan for HIV and AIDS, STIs and TB for KwaZulu-Natal Review Preliminary Findings Provincial Council on AIDS.
From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.
ADVANCING HIV NURSING PRACTICE IN THE COMMUNITY
HIV Care Continuum Ryan White Program - Miami-Dade County
Lowering Barriers to Engage Hard to Find Communities in PrEP
Strategies for Linkage to and Engagement in Care
Hypertension November 2016
DTES Second Generation Strategy
Nanette Brey Magnani, EdD, HIVQUAL US April 4, 2012
Melanie L. Fritza Ronald J. Lubelchek, MD a, b, c*
CIIS Implementation in Progress Mari-Lynn Drainoni, PhD, MEd
Jeopardy Game Hosted by PHDP Jamaica MODULE 4 Treatment Literacy.
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
Believed discrimination occurred because of their:
MHEALTH to Improve Health: Effectiveness of a weekly text messaging intervention to improve ART adherence and HIV Viral Load: WelTel OAKTREE. M.C.M. Murray1,2,3,
Adetunji Adejumo, MD; Cynthia Lee MA; Sharon Mannheimer, MD
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
VL patient support: General education at different levels
Dr. Velephi Okello, Principal Investigator, MaxART Trial
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
2017 HIV Care Cascade Submission
Care Cascade 2017 Jameela Yusuff MD MPH FACP
Our Strategies for Viral Load Suppression
Needs Assessment Slides for Module 4
Hypertension November 2016
Quality Improvement Team
Behavioral Health Clinic Quality Measures(BHCQMs)
EAC for children.
Greater Baltimore HIV Heath Services
Florida International University
Ryan White HIV/AIDS Program Service Report (RSR)
Illustrative Cluster Detection and Response Strategy
Prevalence of recent alcohol and substance use in persons with HIV and associations with HIV care cascade outcomes in South Africa Adrienne E Shapiro,
Presentation transcript:

The Hotspotters Retention and VL Supression Monitoring Project Ivy Clinic, Arnot Ogden Medical Center DRAFT Quality Improvement Team  Clinical Coordinator – Joan Cain, FNP-C, HIV Specialist  Treatment Adherence Counselor – Lynn Bassler  Program Asst./QI Coordinator – Anna Lechowska  Case Managers – Shannon Sprague and Lawanda Robinson

Purpose Purpose:  To test a care coordination process for managing patients – “Hot Spotters” who fall out of care and need targeted interventions and  To improve patient care for those patients who are not retained and who do not have suppressed Viral Loads <100 copies by testing targeted interventions

Performance Measures HIVQUAL Retention measure: Number of unique clients with at least 2 or more medical visits during the past 12 months, one in each 6-month period _______________________________________________ Number of unique clients with at least 1 medical visit during the past 12 months

HIVQUAL Viral Load Suppression Guidelines Value derived from the last viral load measurement of the review period  Not Suppressed Detectable based on clinic lab definition No measurement in the last half of the review period  Suppressed Undetectable based on clinic lab definition Most recent measure in the last half of the review period Data reported by gender, race, ethnicity, risk/ transmission

5 Viral Load Measure Viral Load Suppression measure: All* patients with the most recent VL Test within the last 6 months of the measurement year that are considered undetectable based on clinic lab definition - <100 copies _______________________________________ All* eligible patients with at least one medical visit in each of the 6 months in the measurement year and at least on ART for 3 months.

HIVQUAL Viral Load Suppression Guidelines Value derived from the last viral load measurement of the review period  Not Suppressed Detectable based on clinic lab definition No measurement in the last half of the review period  Suppressed Undetectable based on clinic lab definition Most recent measure in the last half of the review period Data reported by gender, race, ethnicity, risk/ transmission

Viral Load Suppression Performance Measure Numerator: All* patients with a VL Test ((or measure) within the last 6 months of the measurement year that are considered undetectable based on clinic lab definition Denominator: All* eligible patients with at least one medical visit in each of the 6 months in the measurement year. * Repeat measure replacing “All” with African American patients, Latino patients, gay and bi- sexual male patients, male/female, by risk/transmission

Background Information Clinic’s Info : active clients in March 2012, 96% of them on HAART. Patients’ numbers doubled in last 8 years. (10 patients not on HAART) - Clinic’s goal is to see each patient every 3 months for primary care visit with NP and bloodwork, and twice a year to follow up with dietician, medical case manager and treatment adherence counselor. - 3 locations: Elmira (main), Ithaca and Bath (most recently established), cover Chemung, Tompkins, Schuyler, Steuben, Tioga, and growing into Cortland and Seneca counties.

Baseline Data – based on IPRO and HIVQUAL reporting 2010 Data: Retention rate – 91.6% HIV viral load suppression – 77.6% undetectable (less than 48) 2011 Data: Retention – 94.6% HIV viral load suppression:  57.6% undetectable (less than 20)  72.7% VL suppressed at less than 48  14% clients with VL over 100.

Improvement Goals Increase percentage of clients with HIV primary care visits every 3 months (or at least one visit in each 6 month-period) Increase percentage of clients with undetectable HIV VL (less than 100).

Improvement steps Identify clients most likely to miss appointments and develop problems with treatment adherence. Identify patterns in behavior that my lead to retention problems and medication non-adherence, develop prevention and care coordination plan and approach.

Model of Hotspotters team activities – test new process Patients on HAART with HIV viroload over 100 Patients not seen in 6 months CM follows up with CBOCM follows up with the patient □ Schedule medical appointment with the provider □ Schedule case management review with CM (if needed, to follow up on patient’s issues) Review most recent clinic and adherence data for the client Identify individual retention problems Contact the patient with lab results (NP) □ Schedule f/u bloodwork □ Schedule visit with NP to discuss the lab results □ Schedule appointment with Treatment Adherence Counselor Collection of Data by QI Coordinator (based on Excell spreadsheets, eMD and AIRS reporting) □ Review outcome of interventions at the end of the month. □ Update viroload information and follow up on scheduled appointments □ Review client’s chart in eMD for possible coordination of care needs. Meeting of the Team (second Friday of the month), review of the data

Treatment Adherence for people with VL Self-Assessment Do they know which meds to take, how many, and when? Review Missed Doses Are they missing doses of their medication? Medication Education Provide medication and treatment education. Identify Barriers Figure out how many doses missing and why? Review Medication Guidelines Are they taking it appropriately (i.e., with food, without splitting, with other meds)? Develop Care Plan Set client-focused goals to overcome adherence barriers (if client is agreeable). Resistance Testing Determine if resistance has occurred and if a med change needs to happen. Reassess for Readiness Determine if client is ready to take medications (confidence and importance).

Overall Findings Start of the project – November clients on the list - 25% no-shows - 75% VL over % female/77% male Current data - March clients - 13% no-shows - 13% new clients - 73% VL over % female/74%male 22 patient from November list remain on it in March 18%(4) no-shows/82%(18) VL over % female/68% male (note: higher number of women remaining on list for longer time) All of the clients remaining on the list were outreached to schedule an appointment, repeat VL, run a resistance test and/or see Treatment Adherence Counselor. Patients with VL over 100: 61%(11) VL down, 28% (5) VL up, 2 – no change 2 clients restarted medications recently 5 clients with severe mental health problems – 4 enrolled in MH care 1 client refusing care, 1 about to be closed (MIA).